Abstract: The present invention relates to a medicament delivery device comprising a housing (60), which housing is arranged to accommodate a medicament container (62); a drive unit (86) operably arranged to act on said medicament container (62) for expelling a dose of medicament; an activation unit (74) operably connected to said drive unit for activating said drive unit (86); said drive unit (86) comprising an actuation element (84) arranged movable inside the housing (60) from an initial position prior to activation, to a displaced position after activation; at least a first NFC-chip (170, 172) comprising specific information arranged on said actuation element; at least one shielding element (174) arranged to said housing, such as to shield said at least first NFC-chip (170, 172) from being read by an NFC-chip reader when said actuation element (84) is either in the initial position or in the displaced position.

Abstract: The present invention relates to a medicament delivery device comprising a housing (60), which housing is arranged to accommodate a medicament container (62); a drive unit (86) operably arranged to act on said medicament container (62) for expelling a dose of medicament; an activation unit (74) operably connected to said drive unit for activating said drive unit (86); said drive unit (86) comprising an actuation element (84) arranged movable inside the housing (60) from an initial position prior to activation, to a displaced position after activation; at least a first NFC-chip (170, 172) comprising specific information arranged on said actuation element; at least one shielding element (174) arranged to said housing, such as to shield said at least first NFC-chip (170, 172) from being read by an NFC-chip reader when said actuation element (84) is either in the initial position or in the displaced position.

Abstract: The present disclosure relates to a medicament delivery device for injection of a medicament. The medicament delivery device comprises a housing (3) arranged to receive a medicament delivery member, a medicament delivery member cover (7) received by the housing (3), which medicament delivery member cover (7) has a cap-fitting portion (7a), wherein the medicament delivery member cover (1) is moveable relative to the housing (3) from an extended position in which the cap-fitting portion (7a) extends from the housing (3), to a retracted position in which the medicament delivery member cover (7) is biased towards the extended position, and a cap (11) arranged to receive the cap-fitting portion (7a), wherein the medicament delivery member cover (7) and the cap (1) comprise a tamper evidence mechanism which is activated by removal of the cap (11) from the cap-fitting portion (7a).

Abstract: The present invention relates to a medicament delivery device comprising a housing (60), which housing is arranged to accommodate a medicament container (62); a drive unit (86) operably arranged to act on said medicament container (62) for expelling a dose of medicament; an activation unit (74) operably connected to said drive unit for activating said drive unit (86); said drive unit (86) comprising an actuation element (84) arranged movable inside the housing (60) from an initial position prior to activation, to a displaced position after activation; at least a first NFC-chip (170, 172) comprising specific information arranged on said actuation element; at least one shielding element (174) arranged to said housing, such as to shield said at least first NFC-chip (170, 172) from being read by an NFC-chip reader when said actuation element (84) is either in the initial position or in the displaced position.

Abstract: The present invention relates to a signal delaying assembly for a medicament delivery device, said assembly comprising a delay female member containing a fluid, a delay male member having at least one passage, a delay unit connected to the delay female member or to the delay male member, wherein a relative movement between the male member and the female member and towards each other causes the transfer of said fluid from said female member through the at least one passage for slowing said movement, characterized in that the delay unit is releasably connected to a signal generating assembly for delaying at least one feedback signal.

Abstract: A medicament delivery device is presented having a housing with a distal and a proximal end, the housing being adapted to receive a medicament container with a delivery member or with a connectable delivery member for delivery of a medicament. The device also has a drive mechanism arranged to act on a plunger rod, which plunger rod in turn is arranged to act on the medicament container for providing automatic delivery of the medicament and a hold-release mechanism interactively connected to the drive mechanism for releasing the drive mechanism from a biased position. A delayable signal generating mechanism generates an audible and/or tactile and/or visual signal indicating that the medicament has been completely delivered, which delayable signal generating mechanism is operably connected between said pre-tensioned drive mechanism and said plunger rod.

Abstract: The present disclosure relates to a medicament delivery device for injection of a medicament. The medicament delivery device comprises a housing (3) arranged to receive a medicament delivery member, a medicament delivery member cover (7) received by the housing (3), which medicament delivery member cover (7) has a cap-fitting portion (7a), wherein the medicament delivery member cover (1) is moveable relative to the housing (3) from an extended position in which the cap-fitting portion (7a) extends from the housing (3), to a retracted position in which the medicament delivery member cover (7) is biased towards the extended position, and a cap (11) arranged to receive the cap-fitting portion (7a), wherein the medicament delivery member cover (7) and the cap (1) comprise a tamper evidence mechanism which is activated by removal of the cap (11) from the cap-fitting portion (7a).

Abstract: The present invention relates to a signal delaying assembly for a medicament delivery device, said assembly comprising a delay female member containing a fluid, a delay male member having at least one passage, a delay unit connected to the delay female member or to the delay male member, wherein a relative movement between the male member and the female member and towards each other causes the transfer of said fluid from said female member through the at least one passage for slowing said movement, characterized in that the delay unit is releasably connected to a signal generating assembly for delaying at least one feedback signal.

Abstract: The present invention relates to a medicament delivery device comprising a housing (60), which housing is arranged to accommodate a medicament container (62); a drive unit (86) operably arranged to act on said medicament container (62) for expelling a dose of medicament; an activation unit (74) operably connected to said drive unit for activating said drive unit (86); said drive unit (86) comprising an actuation element (84) arranged movable inside the housing (60) from an initial position prior to activation, to a displaced position after activation; at least a first NFC-chip (170, 172) comprising specific information arranged on said actuation element; at least one shielding element (174) arranged to said housing, such as to shield said at least first NFC-chip (170, 172) from being read by an NFC-chip reader when said actuation element (84) is either in the initial position or in the displaced position.

Abstract: Compounds of formula (I) in which R, R1, R2, n and X1 have the meanings given in the specification are Factor Xa inhibitors useful in the treatment of thrombotic disorders.

Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.

Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.

Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (1) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.

Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.

Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (I); or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful, e.g., for treating Type 2 diabetes and/or obesity.

Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is useful for treating Type II diabetes and/or obesity.

Abstract: Compounds of formula (I) in which R1, R2 and X4 have the meanings given in the specification are Factor Xa inhibitors useful in the treatment of thrombotic disorders.

Abstract: A novel class of tricyclic compounds of the following formula (I) is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.

Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.

Abstract: The present invention relates to a ?3 adrenegc receptor agonist of Formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetess and/or obesity.